1. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. Issue 1 (6th January 2015) Authors: Packer, Milton; McMurray, John J.V.; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael; Andersen, Karl; Arango, Juan Luis; Arnold, J. Malcolm; Bělohlávek, Jan; Böhm, Michael; Boytsov, Sergey... Journal: Circulation Issue: Volume 131:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure. Issue 1 (6th January 2015) Authors: Packer, Milton; McMurray, John J.V.; Desai, Akshay S.; Gong, Jianjian; Lefkowitz, Martin P.; Rizkala, Adel R.; Rouleau, Jean L.; Shi, Victor C.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael; Andersen, Karl; Arango, Juan Luis; Arnold, J. Malcolm; Bělohlávek, Jan; Böhm, Michael; Boytsov, Sergey... Journal: Circulation Issue: Volume 131:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials. (27th October 2020) Authors: Teerlink, John R.; Diaz, Rafael; Felker, G. Michael; McMurray, John J.V.; Metra, Marco; Solomon, Scott D.; Adams, Kirkwood F.; Anand, Inder; Arias‐Mendoza, Alexandra; Biering‐Sørensen, Tor; Böhm, Michael; Bonderman, Diana; Cleland, John G.F.; Corbalan, Ramon; Crespo‐Leiro, Maria G.; Dahlström, Ul... Journal: European journal of heart failure Issue: Volume 22:Number 11(2020) Page Start: 2160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. (9th October 2018) Authors: Ramires, Felix J.A.; Martinez, Felipe; Gómez, Efraín A.; Demacq, Caroline; Gimpelewicz, Claudio R.; Rouleau, Jean L.; Solomon, Scott D.; Swedberg, Karl; Zile, Michael R.; Packer, Milton; McMurray, John J.V. Journal: ESC heart failure Issue: Volume 5:Number 6(2018) Page Start: 1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗